← Leaderboards
Genhong Cheng
University Of California Los Angeles
$27,178,241
Attributed
$29,695,208
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–22$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$29,695,208 · 15
By mechanism
R01$23,080,358 · 10
U19$4,105,906 · 2
P50$1,711,566 · 1
R21$412,378 · 1
R56$385,000 · 1
Top collaborators
- Jae U Jung5 shared
- Karin Nielsen5 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Xian-Jie Yang$9,325,084
- Robert L Modlin$53,861,964
- Michael E Jung$1,638,163
- Julia Heck$1,353,704
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingInfectionResponseCellsBaseGenesPathway InteractionsImmune ResponseMolecularCytokineInterferon Type IPathogenProgramsLeadImmunePlayPreventComplexHost DefenseSignal TransductionToll-Like ReceptorsViralInterferonsInflammatory
Grant awards (80)
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV$750,035
R01 · FY2022 · AI
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection$380,328
R01 · FY2022 · AI · contact PI
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV$747,874
R01 · FY2021 · AI
Viral Mediated Type I Interferon Induction$385,000
R01 · FY2021 · AI · contact PI
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection$380,328
R01 · FY2021 · AI · contact PI
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV$750,411
R01 · FY2020 · AI
Viral Mediated Type I Interferon Induction$385,000
R01 · FY2020 · AI · contact PI
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection$380,328
R01 · FY2020 · AI · contact PI
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV$750,427
R01 · FY2019 · AI
Acute and Long Term Immune Responses to Radiation and Mitigation$402,341
U19 · FY2019 · AI · contact PI
Viral Mediated Type I Interferon Induction$385,000
R01 · FY2019 · AI · contact PI
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV$776,704
R01 · FY2018 · AI
Viral Mediated Type I Interferon Induction$687,808
R01 · FY2018 · AI · contact PI
Acute and Long Term Immune Responses to Radiation and Mitigation$423,705
U19 · FY2018 · AI · contact PI
Viral Mediated Type I Interferon Induction$605,146
R01 · FY2017 · AI · contact PI
Acute and Long Term Immune Responses to Radiation and Mitigation$357,950
U19 · FY2017 · AI · contact PI
Acute and Long Term Immune Responses to Radiation and Mitigation$427,384
U19 · FY2016 · AI · contact PI
Interferon Inducible Gene Programs in Leprosy$365,322
P50 · FY2016 · AR · contact PI
Viral Mediated Type I Interferon Induction$378,400
R01 · FY2015 · AI · contact PI
Interferon Inducible Gene Programs in Leprosy$365,322
P50 · FY2015 · AR · contact PI
Acute and Long Term Immune Responses to Radiation and Mitigation$354,289
U19 · FY2015 · AI · contact PI
Viral Mediated Type I Interferon Induction$378,400
R01 · FY2014 · AI · contact PI
Mechanisms of Biodefense by Toll-Like Receptors$370,138
R01 · FY2014 · AI · contact PI
Mitigation of Radiation Damage by Mechanisms of Innate Immune Regulation$343,572
U19 · FY2014 · AI · contact PI
Interferon Inducible Gene Programs in Leprosy$332,516
P50 · FY2014 · AR · contact PI
Mitiagrion of Radiation Damage by Mechanisms of Innate Immune Regulation$397,788
U19 · FY2013 · AI · contact PI
Viral Mediated Type I Interferon Induction$355,695
R01 · FY2013 · AI · contact PI
Mechanisms of Biodefense by Toll-Like Receptors$347,930
R01 · FY2013 · AI · contact PI
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections$345,421
R01 · FY2013 · AI · contact PI
Interferon Inducible Gene Programs in Leprosy$315,890
P50 · FY2013 · AR · contact PI
Mitiagrion of Radiation Damage by Mechanisms of Innate Immune Regulation$561,705
U19 · FY2012 · AI · contact PI
Viral Mediated Type I Interferon Induction$450,589
R01 · FY2012 · AI · contact PI
Mechanisms of Biodefense by Toll-Like Receptors$370,138
R01 · FY2012 · AI · contact PI
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections$367,469
R01 · FY2012 · AI · contact PI
Interferon Inducible Gene Programs in Leprosy$332,516
P50 · FY2012 · AR · contact PI
IKKa-Dependent Negative Feedback Control of Non-Canonical NF-kB Activation$186,939
R21 · FY2012 · AI · contact PI
Mitiagrion of Radiation Damage by Mechanisms of Innate Immune Regulation$473,378
U19 · FY2011 · AI · contact PI
Viral Mediated Type I Interferon Induction$378,400
R01 · FY2011 · AI · contact PI
Mechanisms of Biodefense by Toll-Like Receptors$370,138
R01 · FY2011 · AI · contact PI
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections$367,469
R01 · FY2011 · AI · contact PI
Regulation of Type 2 NF-kappaB Activation and Inflammation$277,151
R01 · FY2011 · GM · contact PI
IKKa-Dependent Negative Feedback Control of Non-Canonical NF-kB Activation$225,439
R21 · FY2011 · AI · contact PI
Mechanisms of Biodefense by Toll-Like Receptors$373,877
R01 · FY2010 · AI · contact PI
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections$371,181
R01 · FY2010 · AI · contact PI
Mitiagrion of Radiation Damage by Mechanisms of Innate Immune Regulation$363,794
U19 · FY2010 · AI · contact PI
Viral Mediated Type I Interferon Induction$320,420
R01 · FY2010 · AI · contact PI
Regulation of Type 2 NF-kappaB Activation and Inflammation$279,950
R01 · FY2010 · GM · contact PI
Viral Mediated Type I Interferon Induction$323,656
R01 · FY2009 · AI · contact PI
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections$312,441
R01 · FY2009 · AI · contact PI
Regulation of Type 2 NF-kappaB Activation and Inflammation$282,778
R01 · FY2009 · GM · contact PI
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections$385,000
R56 · FY2008 · AI · contact PI
Mechanisms of Biodefense By Toll-Like Receptors$347,401
R01 · FY2008 · AI · contact PI
Viral Mediated Type I Interferon Induction$323,656
R01 · FY2008 · AI · contact PI
Role of RIP2 in Biodefense Against Listeria Infection$323,350
R01 · FY2008 · AI · contact PI
Regulation of Type 2 NF-kappaB Activation and Inflammation$282,778
R01 · FY2008 · GM · contact PI
Mechanisms of Biodefense By Toll-Like Receptors$354,130
R01 · FY2007 · AI · contact PI
Viral Mediated Type I Interferon Induction$329,924
R01 · FY2007 · AI · contact PI
Role of RIP2 in Biodefense Against Listeria Infection$329,612
R01 · FY2007 · AI · contact PI
The Apoptotic Role of MEKK1 in Cancer Chemotherapy$257,383
R01 · FY2007 · CA · contact PI
Mechanisms of Biodefense By Toll-Like Receptors$367,824
R01 · FY2006 · AI · contact PI
Viral Mediated Type I Interferon Induction$339,778
R01 · FY2006 · AI · contact PI
Role of RIP2 in Biodefense Against Listeria Infection$339,457
R01 · FY2006 · AI · contact PI
The Apoptotic Role of MEKK1 in Cancer Chemotherapy$265,071
R01 · FY2006 · CA · contact PI
Mechanisms of Biodefense By Toll-Like Receptors$375,707
R01 · FY2005 · AI
Role of RIP2 in Biodefense Against Listeria Infection$347,251
R01 · FY2005 · AI
The Apoptotic Role of MEKK1 in Cancer Chemotherapy$271,450
R01 · FY2005 · CA
Using Genechips to Study the Immunological Roles of CD40$250,461
R01 · FY2005 · CA
Mechanisms of Biodefense By Toll-Like Receptors$376,492
R01 · FY2004 · AI
Role of RIP2 in Biodefense Against Listeria Infection$345,001
R01 · FY2004 · AI
The Apoptotic Role of MEKK1 in Cancer Chemotherapy$271,450
R01 · FY2004 · CA
Using Genechips to Study the Immunological Roles of CD40$250,539
R01 · FY2004 · CA
The Apoptotic Role of MEKK1 in Cancer Chemotherapy$271,450
R01 · FY2003 · CA
CD40 SIGNALING THROUGH TNF RECEPTOR ASSOCIATED FACTORS$261,739
R01 · FY2003 · GM
Using Genechips to Study the Immunological Roles of CD40$250,615
R01 · FY2003 · CA
CD40 SIGNALING THROUGH TNF RECEPTOR ASSOCIATED FACTORS$323,651
R01 · FY2002 · GM
Using Genechips to Study the Immunological Roles of CD40$250,891
R01 · FY2002 · CA
CD40 SIGNALING THROUGH TNF RECEPTOR ASSOCIATED FACTORS$409,181
R01 · FY2001 · GM
Using Genechips to Study the Immunological Roles of CD40$246,289
R01 · FY2001 · CA
CD40 SIGNALING THROUGH TNF RECEPTOR ASSOCIATED FACTORS$239,529
R01 · FY2000 · GM
CD40 SIGNALING THROUGH TNF RECEPTOR ASSOCIATED FACTORS$92,268
R01 · FY2000 · GM